U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07893223) titled 'Vancomycin Exposure and Biomarker Tracking Using Real-time Monitoring of Interstitial Fluid' on Aug. 26.
Brief Summary: The goal of this observational study is to understand whether a wearable sensor (the Nutromics Sensor Device) can accurately measure drug and biomarker levels in the fluid just under the skin (interstitial fluid), instead of needing repeated blood draws, in adults admitted to hospital who are being treated with the antibiotic vancomycin or who are being monitored for signs of sepsis. The main questions it aims to answer are:
* How closely do interstitial fluid levels of vancomycin match levels measured in the bloo...